HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

18- (5- methyl- 2,5- diazabicyclo(2.2.1)heptan- 2- yl)- 18- oxooctadec- 9- en- 7- yl phenylacetate

structure in first source

Also Known As:

PhAR-DBH-Me

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Monounsaturated Fatty Acids: 676
      - Oleic Acids: 67
        18-(5-methyl-2,5-diazabicyclo(2.2.1)heptan-2-yl)-18-oxooctadec-9-en-7-yl phenylacetate: 2
Organic Chemicals: 133
- Aza Compounds: 3
  - Azabicyclo Compounds
    - 18-(5-methyl-2,5-diazabicyclo(2.2.1)heptan-2-yl)-18-oxooctadec-9-en-7-yl phenylacetate: 2
Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - Azabicyclo Compounds
      - 18-(5-methyl-2,5-diazabicyclo(2.2.1)heptan-2-yl)-18-oxooctadec-9-en-7-yl phenylacetate: 2

Experts

1.	González-Anduaga, Gloria Melisa: 1 article (10/2020)
2.	López-Ortíz, Manuel: 1 article (10/2020)
3.	Navarrete, Andrés: 1 article (10/2020)
4.	Palomino-Hernández, Oscar: 1 article (10/2020)
5.	Quiñonez-Bastidas, Geovanna Nallely: 1 article (10/2020)
6.	Regla, Ignacio: 1 article (10/2020)
7.	Rocha-González, Héctor Isaac: 1 article (10/2020)

Related Diseases

1.	Neuralgia (Stump Neuralgia) 10/01/2020 - "The antiallodynic effect of PhAR-DBH-Me was evaluated on two models of neuropathic pain, and the potential roles of CB1, CB2, and TRPV1 receptors as molecular targets of PhAR-DBH-Me were studied. " 12/01/2022 - "Moreover, PhAR-DBH-Me and tramadol combination showed a synergistic interaction in neuropathic pain rats induced by SNL but not for cisplatin-induced neuropathy. " 12/01/2022 - "PhAR-DBH-Me, tramadol, and their combination produced an antiallodynic effect on spinal nerve ligation (SNL) and cisplatin-induced neuropathic pain in rats. "
2.	Hyperalgesia 10/01/2020 - "Then, tactile allodynia was determined, and animals were treated with logarithmic doses of PhAR-DBH-Me (3.2-100 mg/kg, i.p.). " 12/01/2022 - "Results show that the combination of PhAR-DBH-Me and tramadol attenuates the allodynia in SNL rats; the acute toxicology analysis suggests that this combination could be considered safe in administered doses." 10/01/2020 - "Systemic administration of PhAR-DBH-Me reduced the SNL- and cisplatin-induced allodynia. "

Related Drugs and Biologics

1.	Cisplatin (Platino)
2.	Tramadol (K315)

Related Therapies and Procedures

1.	Ligation